GreyWolf Therapeutics
UKEntry
2018
Hold
8yr
Status
Active
Who owns GreyWolf Therapeutics?
GreyWolf Therapeutics is currently owned by Andera Partners through BioDiscovery 5 (2017 vintage), since 2018. Across its history, GreyWolf Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Andera PartnersBioDiscovery 5 · 2017 · VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2018 · present
Andera PartnersActive
2018 · present(8yr) · BioDiscovery 5 · 2017 · VC
More from BioDiscovery 5
Other portfolio companies in the same fund.
France
Belgium
Netherlands
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack GreyWolf Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy GreyWolf Therapeutics?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on GreyWolf Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue